Eligibility for Cardiovascular Risk Reduction Therapy in the United States Based on SELECT Trial Criteria: Insights From the National Health and Nutrition Examination Survey

Yuan Lu; Yuntian Liu; Ania M Jastreboff; Rohan Khera; Chima D Ndumele; Fatima Rodriguez; Karol E Watson; Harlan M Krumholz

doi:10.1161/CIRCOUTCOMES.123.010640

Eligibility for Cardiovascular Risk Reduction Therapy in the United States Based on SELECT Trial Criteria: Insights From the National Health and Nutrition Examination Survey

Circ Cardiovasc Qual Outcomes. 2024 Jan;17(1):e010640. doi: 10.1161/CIRCOUTCOMES.123.010640. Epub 2023 Nov 11.

Authors

Yuan Lu^{1

2

3}, Yuntian Liu¹, Ania M Jastreboff^{3

4

5}, Rohan Khera^{1

2}, Chima D Ndumele⁶, Fatima Rodriguez⁷, Karol E Watson⁸, Harlan M Krumholz^{1

2

3

6}

Affiliations

¹ Center for Outcomes Research and Evaluation, Yale New Haven Hospital, CT (Y. Lu, Y. Liu, R.K., H.M.K.).
² Section of Cardiovascular Medicine, Department of Internal Medicine (Y. Lu, R.K., H.M.K.), Yale School of Medicine, New Haven, CT.
³ Yale Obesity Research Center (Y-Weight) (Y. Lu, A.M.J., H.M.K.), Yale School of Medicine, New Haven, CT.
⁴ Department of Medicine (Endocrinology and Metabolism) (A.M.J.), Yale School of Medicine, New Haven, CT.
⁵ Department of Pediatrics (Pediatric Endocrinology) (A.M.J.), Yale School of Medicine, New Haven, CT.
⁶ Department of Health Policy and Management, Yale School of Public Health, New Haven, CT (C.D.N., H.M.K.).
⁷ Division of Cardiovascular Medicine, School of Medicine, Stanford University, CA (F.R.).
⁸ David Geffen School of Medicine, University of California, Los Angeles (K.E.W.).

No abstract available

Keywords: adult; cardiovascular diseases; ethnicity; obesity; overweight.

MeSH terms

Cardiovascular Diseases* / diagnosis
Cardiovascular Diseases* / epidemiology
Cardiovascular Diseases* / prevention & control
Clinical Trials as Topic
Heart Disease Risk Factors
Humans
Nutrition Surveys
Risk Factors
United States / epidemiology

MeSH terms

Grants and funding